Artikelen door Leonie White-Scholten

Abbott opent nieuwe fabriek in Weesp

Abbott opent woensdag officieel een nieuwe fabriek op haar productielocatie in Weesp. Met de opening van het nieuwe gebouw breidt de farmaceut de productie uit van dydrogesteron, een geneesmiddel dat wordt gebruikt om een progesteron-insufficiëntie bij vrouwen te behandelen. De nieuwe fabriek vertegenwoordigt een totale investeringswaarde van 80 miljoen Amerikaanse dollar en bevat dezelfde moderne […]

‘Niemand zal onze CRISPR-banaan willen’

Hoe de Europese regels rond genbewerking een poging om de banaan te redden torpederen. Het valt niet op wanneer je in de supermarkt langs de goed gevulde schappen loopt, maar het gaat niet goed met de banaan. Ziektes tasten wereldwijd plantages aan. Eet je een banaan, dan is dat doorgaans een Cavendish. Het gros van […]

FDA approves first-of-its kind targeted RNA-based therapy

The Food and Drug Administration approved Alnylam’s patisiran for the treatment of peripheral nerve disease (polyneuropathy), which is caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for patients with polyneuropathy caused by hATTR, a rare, debilitating and often fatal genetic disease characterized by the buildup of abnormal amyloid protein in peripheral nerves, […]

,

Celebrating European Biotech Week 2018

EuropaBio is delighted to announce European Biotech Week 2018. Between 24 – 30th of September, the EU will, for the sixth time,  witness a week packed full of biotech-focused activities and events. European Biotech Week will be held alongside simlar initiatives, planned across 4 continents as part of Global Biotech Week. This year, we build […]

Boehringer Ingelheim takes its first step into gene therapy

The company have together with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), consisting of Imperial College London and the Universities of Oxford and Edinburgh, Imperial Innovations, and Oxford BioMedica (OXB) announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF). The new partnership brings together the academic partners’ […]

How a humble Australian bee could help the world’s plastic problem

There’s a buzz among researchers across the Tasman as they recruit native Australian bees to fight the war on waste by helping create a new bioplastic. The biotech start-up Humble Bee aims to take the nesting material from Banksia bees to produce a water-repellent and flame-resistant form of natural plastic. The New Zealand-based company is attempting to […]

GM Plants Could Provide Balanced Diet for Salmon

Scientists believe a new feed solution for Atlantic farmed salmon – created from a genetically modified plant – could help relieve pressure on stressed marine resources. The University of Stirling, in collaboration with Rothamsted Research, is conducting a study into the potential benefits of using the customised feed to improve access to omega-3 fish oils, […]

ENPICOM Releases Immune Repertoire Sequencing Analysis Platform to Personalize Immunotherapies

ENPICOM finalized development and released the first version of their ImmunoGenomiX (IGX) platform to support the development, patient stratification and treatment monitoring of immunotherapies. The adaptive immune system, also known as the acquired immune system, is a subsystem of the overall immune system that is composed of T and B lymphocytes, which eliminate pathogens or […]

SelectMDx-studie toont kosteneffectiviteit aan in Amerikaanse Gezondheidszorg

MDxHealth meldt de publicatie in The Journal of Urology van een studie die de kosteneffectiviteit van SelectMDx® voor prostaatkanker valideert. SelectMDx® is een niet-invasieve ‘vloeibare biopsie’ test die helpt bij het identificeren van patiënten met een verhoogd risico op agressieve prostaatkanker.   De studie toonde aan dat het opnemen van SelectMDx in het Amerikaanse gezondheidszorgsysteem […]